Koninklijke Philips (PHG) Long-Term Debt Repayments (2009 - 2016)
Koninklijke Philips (PHG) recorded quarterly Long-Term Debt Repayments of -$67.0 million in Q3 2016, down 79.62% quarter-over-quarter from -$37.3 million in Q2 2016, and up 25.67% on a YoY basis from -$53.3 million in Q4 2015.
Koninklijke Philips (PHG) Long-Term Debt Repayments (2009 - 2016) Analysis & Trends
Koninklijke Philips' Long-Term Debt Repayments history runs 8 years deep, the most recent figure standing at -$67.0 million for Q3 2016.
- In Q3 2016, Long-Term Debt Repayments rose 25.67% year-over-year to -$67.0 million; the TTM figure through Sep 2016 stood at -$227.1 million (up 60.3% YoY), while the FY2015 annual figure was -$114.0 million, changed N/A from the prior year.
- Long-Term Debt Repayments was -$67.0 million for Q3 2016 at Koninklijke Philips, down from -$37.3 million in the prior quarter.
- In the past five years, Long-Term Debt Repayments ranged from a high of -$8.8 million in Q1 2016 to a low of -$818.3 million in Q4 2012.
- Historically, Long-Term Debt Repayments has averaged -$220.6 million across 5 years, with a median of -$60.3 million in 2013.
- The sharpest annual moves came in 2012 and 2013: Long-Term Debt Repayments surged 91.92% in 2012, then grew 7.7% in 2013.
- A 5-year view of Long-Term Debt Repayments shows it stood at -$818.3 million in 2012, then soared by 93.46% to -$53.5 million in 2013, then tumbled by 677.41% to -$416.2 million in 2014, then jumped by 72.61% to -$114.0 million in 2015, then jumped by 41.25% to -$67.0 million in 2016.
- The last three Long-Term Debt Repayments figures came in at -$67.0 million (Q3 2016), -$37.3 million (Q2 2016), and -$8.8 million (Q1 2016), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.42 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 1.00 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | -66.97 Mn |
| Sep 30, 2016 | -66.97 Mn |
| Jun 30, 2016 | -37.29 Mn |
| Jun 30, 2016 | -37.29 Mn |
| Mar 31, 2016 | -8.82 Mn |
| Mar 31, 2016 | -8.82 Mn |
| Dec 31, 2015 | -114.00 Mn |
| Dec 31, 2015 | -114.00 Mn |
| Sep 30, 2015 | -90.10 Mn |
| Sep 30, 2015 | -90.10 Mn |
| Jun 30, 2015 | -43.10 Mn |
| Jun 30, 2015 | -43.10 Mn |
| Mar 31, 2015 | -22.60 Mn |
| Mar 31, 2015 | -22.60 Mn |
| Dec 31, 2014 | -416.19 Mn |
| Dec 31, 2014 | -416.19 Mn |
| Jun 30, 2013 | -53.54 Mn |
| Jun 30, 2013 | -53.54 Mn |
| Mar 31, 2013 | -29.05 Mn |
| Mar 31, 2013 | -29.05 Mn |